Cellebrite DI Income Statement (2020-2025) | CLBT

Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue 53.24M57.17M53.28M59.17M65.89M67.91M62.38M62.57M71.67M74.02M71.23M76.68M84.18M93.01M89.58M95.71M106.86M109.05M107.55M113.28M126.03M128.82M
Cost of Revenue 15.16M17.76M16.52M18.51M20.12M21.24M23.26M24.89M25.57M23.67M27.60M26.75M26.87M29.59M32.06M32.32M32.49M35.52M38.77M38.69M38.80M38.56M
Gross Profit 43.74M46.65M45.08M49.10M53.93M55.57M51.40M49.48M57.14M61.89M58.83M63.65M71.30M78.10M76.32M79.45M91.41M91.42M90.06M95.60M105.72M109.13M
Operating items
Amortization - Intangibles 0.61M0.66M0.66M0.66M0.83M0.80M0.84M0.84M0.87M0.93M0.79M0.86M0.93M
Research & Development 12.90M14.77M14.89M15.39M16.43M18.83M19.58M19.68M21.64M19.73M21.13M21.05M20.45M21.75M23.20M23.69M25.93M25.60M27.28M28.61M28.12M29.86M
Selling, General & Administrative 6.70M9.05M9.29M6.98M20.48M11.19M10.51M10.51M11.02M8.81M9.96M11.23M10.50M11.75M11.81M10.95M13.56M14.57M11.75M13.89M19.80M19.90M
Restructuring Costs 1.18M1.06M0.39M0.38M0.13M0.26M-0.32M0.05M0.05M0.01M0.21M0.16M
Other Operating Expenses 15.16M17.76M16.52M18.51M20.12M20.06M22.20M24.50M25.19M23.54M27.34M27.07M26.82M29.54M32.05M32.32M32.27M35.52M38.77M38.69M38.64M38.56M
Operating Expenses 34.76M41.58M40.70M40.88M57.02M51.27M53.35M55.07M58.23M52.21M58.69M59.03M57.82M63.10M67.07M66.97M71.97M75.70M77.79M81.18M86.72M88.33M
Operating Income 8.98M5.07M4.39M8.22M3.09M4.31M1.95M-5.60M-1.08M9.67M0.14M4.62M13.48M15.00M9.25M12.49M19.45M15.73M12.27M14.42M18.99M20.80M
EBIT 8.98M5.07M4.39M8.22M3.09M4.31M1.95M-5.60M-1.08M9.67M0.14M4.62M13.48M15.00M9.25M12.49M19.45M15.73M12.27M14.42M18.99M20.80M
Non-operating items
Non Operating Investment Income -1.39M0.12M-1.15M-0.24M-0.26M0.04M-0.04M-0.05M0.09M0.29M-0.52M-0.10M0.84M-0.41M-0.78M0.04M0.20M0.02M
Non Operating Income 0.42M0.60M0.37M0.50M17.81M49.81M56.40M38.47M25.42M-0.57M-38.77M-36.05M-6.63M-27.34M-78.58M-34.50M-223.98M4.17M7.06M6.37M5.30M5.47M
Net income details
EBT 9.40M5.67M4.39M8.72M14.72M54.12M1.95M32.87M24.34M9.10M-38.64M-31.43M6.85M-12.35M-69.33M-22.02M-204.54M19.90M19.33M20.79M24.29M26.27M
Tax Provisions 1.28M2.72M1.16M0.92M6.58M2.24M-0.98M-0.33M-0.76M2.02M1.97M0.92M0.35M2.30M2.04M1.80M2.56M0.63M1.93M1.31M4.10M5.01M
Profit After Tax 8.12M2.95M3.22M7.80M8.14M51.87M2.93M33.20M25.09M7.08M-40.60M-32.35M6.50M-14.65M71.37M23.81M-207.09M19.27M17.40M19.48M20.19M21.26M
Income from Continuing Operations 8.12M2.95M3.22M7.80M8.14M51.87M2.93M33.20M25.09M7.08M-40.60M-32.35M6.50M-14.65M-71.37M-23.81M-207.09M19.27M17.40M19.48M20.19M21.26M
Consolidated Net Income 8.12M2.95M3.22M7.80M8.14M51.87M54.45M32.87M25.09M9.10M-38.64M-31.43M6.85M-12.35M-71.37M-23.81M-204.54M19.27M17.40M19.48M20.19M21.26M
Income towards Parent Company 8.12M2.95M3.22M7.80M8.14M51.87M54.45M32.87M25.09M9.10M-38.64M-31.43M6.85M-12.35M-71.37M-23.81M-204.54M19.27M17.40M19.48M20.19M21.26M
Net Income towards Common Stockholders 8.12M2.95M3.22M7.80M8.14M51.87M54.45M32.87M25.09M9.10M-38.64M-31.43M6.85M-12.35M-71.37M-23.81M-204.54M19.27M17.40M19.48M20.19M21.26M
Additional items
EPS (Basic) 0.070.26M0.07M0.04M0.05-0.18M-0.08M0.23M-0.06-0.20M-0.05M-0.14M0.01M0.25M0.13M0.08M0.07M
EPS (Weighted Average and Diluted) 0.050.39M0.06M0.20M0.07M0.04M0.05-0.18M-0.08M0.23M-0.06-0.20M-0.05M-0.14M0.01M0.25M0.13M0.09M0.07M
Shares Outstanding (Weighted Average) 123.51M30.00470.00600.00182.69M210.00370.0030.00190.15M360.00480.000.00M0.00M70.00150.00240.00320.00
Shares Outstanding (Diluted Average) 157.97M20.00130.00270.00440.00560.00195.39M210.00370.0030.00190.15M360.00480.000.00M0.00M70.00150.00230.00310.00
EBITDA 8.98M5.07M-0.92M-0.29M3.09M4.31M-0.80M-1.58M25.33M8.18M41.07M32.70M7.38M-13.99M-70.93M-24.05M207.93M20.94M16.20M21.23M20.01M21.02M
Tax Rate 13.61%47.93%26.51%10.57%44.71%4.15%-50.57%-1.00%-3.10%22.24%-5.09%-2.93%5.10%-18.65%-2.95%-8.16%-1.25%3.16%9.98%6.32%16.88%19.07%